Welcome to our November analysis replace! Getting concerned with analysis is a vital method to impression meals allergy remedies, training, and consciousness.
This month, we’re highlighting analysis information on:
- Eosinophilic esophagitis (EoE)
- Anaphylaxis
- Peanut allergy
Be aware: The hyperlinks beneath will take you to exterior web sites.
Surveys
Taking Eohilia for EoE?
You might be eligible for a paid research.
In case you are at the moment taking Eohilia, or are a mother or father or caregiver of somebody who’s, you could be eligible to take part in a research.
The way it works:
- See if you happen to qualify: Reply a number of fast inquiries to see if you happen to qualify. You’ll be entered right into a drawing to win a $100 reward card only for finishing the questionnaire, no matter whether or not you qualify.
- Be a part of the research: Should you qualify, you’ll be supplied with extra info and a hyperlink to affix the research.
- Begin your first survey: After getting joined the research, you’ll obtain a hyperlink to your first survey. Individuals obtain a $50 reward card for every survey they full.
This research is being performed by Encourage. Your privateness is necessary to us. We by no means share your private well being info with out your consent.
The aim of this research is to grasp the experiences of people taking Eohilia for EoE.
You’ll not be requested to attempt any new experimental drug as a part of this research.
All research duties could also be accomplished from dwelling. Should you select to take part, you can be requested to finish a complete of 4 surveys over the subsequent yr.
As a thanks in your time, you possibly can earn as much as $200 for finishing all 4 surveys.
When you have questions on this research, please contact workforce@encourage.com
Sponsored by Encourage
SEE IF YOU QUALIFY
Newest Meals Allergy Information
Anaphylaxis
New Research Will Evaluate Nasdepi® Nasal Spray to Customary Epinephrine Injections for Extreme Allergic Reactions
Belhaven Biopharma lately introduced that the Meals and Drug Administration (FDA) has accepted its software to start human research of Nasdepi®. Nasdepi is a needle-free nasal powder type of epinephrine used to deal with extreme allergic reactions referred to as anaphylaxis.
This milestone permits the corporate to begin research that can evaluate Nasdepi to plain epinephrine pictures and auto-injectors. The trial will measure how rapidly and successfully the nasal powder delivers epinephrine within the physique and whether or not it produces protected, anticipated modifications in coronary heart fee and blood strain.
The purpose of this analysis is to make emergency epinephrine simpler to hold and use, particularly for individuals who keep away from auto-injectors due to price, worry of needles, or storage challenges. If profitable, Nasdepi may provide a heat-stable, needle-free possibility for lifesaving allergy therapy.
Meals Allergy
Moonlight Therapeutics Positive aspects FDA Approval to Start Medical Trial of New Allergy Therapy
Moonlight Therapeutics lately acquired approval from the FDA to start its first scientific trial of MOON101, a brand new therapy designed to assist folks with peanut allergy. The research, referred to as SURVEYOR, will check the protection of MOON101 in each adults and kids with peanut allergy symptoms at main U.S. meals allergy facilities.
MOON101 makes use of a small, pores and skin “stamp” that delivers tiny quantities of peanut protein slightly below the pores and skin to assist retrain the immune system and scale back the prospect of extreme allergic reactions. The therapy is designed to be fast and straightforward to make use of at dwelling, taking lower than 5 minutes. This marks an necessary step ahead for households looking for safer, extra handy allergy remedies.
Keep within the loop – get information and analysis updates straight to your inbox with our e-newsletters.
SIGN ME UP FOR UPDATES!
